Selpercatinib or Chemotherapy in RET Fusion-Positive NSCLC

Anne-Marie C Dingemans; Egbert F Smit; Lizza E L Hendriks

doi:10.1056/NEJMc2314327

Selpercatinib or Chemotherapy in RET Fusion-Positive NSCLC

Anne-Marie C Dingemans, Egbert F Smit, Lizza E L Hendriks

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Downloads (Pure)

Original language	English
Pages (from-to)	381-382
Journal	New England Journal of Medicine
Volume	390
Issue number	4
DOIs	https://doi.org/10.1056/NEJMc2314327
Publication status	Published - 25 Jan 2024

Keywords

Humans
Antibodies, Monoclonal, Humanized
Pyrazoles
Pyridines
Proto-Oncogene Proteins c-ret

Access to Document

10.1056/NEJMc2314327

Embargoed Document

Full Text
Final published version, 306 KB
Licence: Taverne
Embargo ends: 1/07/24
Request copy

Cite this

@article{258598e422f843cb85e8cc4cffca00a8,

title = "Selpercatinib or Chemotherapy in RET Fusion-Positive NSCLC",

keywords = "Humans, Antibodies, Monoclonal, Humanized, Pyrazoles, Pyridines, Proto-Oncogene Proteins c-ret",

author = "Dingemans, {Anne-Marie C} and Smit, {Egbert F} and Hendriks, {Lizza E L}",

year = "2024",

month = jan,

day = "25",

doi = "10.1056/NEJMc2314327",

language = "English",

volume = "390",

pages = "381--382",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "MASSACHUSETTS MEDICAL SOCIETY",

number = "4",

}

TY - JOUR

T1 - Selpercatinib or Chemotherapy in RET Fusion-Positive NSCLC

AU - Dingemans, Anne-Marie C

AU - Smit, Egbert F

AU - Hendriks, Lizza E L

PY - 2024/1/25

Y1 - 2024/1/25

KW - Humans

KW - Antibodies, Monoclonal, Humanized

KW - Pyrazoles

KW - Pyridines

KW - Proto-Oncogene Proteins c-ret

U2 - 10.1056/NEJMc2314327

DO - 10.1056/NEJMc2314327

M3 - Comment/Letter to the editor

SN - 0028-4793

VL - 390

SP - 381

EP - 382

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 4

ER -